Hemanext Latest News Updates

Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community

Partnership Will Expand to Include Educational and Donation Event with OneBlood LEXINGTON, Mass., January 17, 2023, – Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., a leading innovator in blood processing, storage, and transfusion...

Science Innovation Forum

Events, Hemanext, News

Science & Innovation Forum – The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury Please note: AABB reserves the right to make updates to this program. When: Thursday, May 5, 2022 4:00 – 5:00 PM (ET)...

Hemanext Submits Hemanext ONE System to FDA For U.S. Marketing Authorization

Hemanext, HemanextInvF, News, Press Release

Innovative Blood Processing and Storage System Received CE Mark Certification for Sale in European Markets Last Year LEXINGTON, Mass., January 5, 2022, PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing and storage technology, announced that it...

Hemanext AABB 2021

Events, Hemanext, News

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs). Learn More...

Join Hemanext at AABB 2022 Virtual

Events, Hemanext, News

Connect with Hemanext at ISBT 2020

Events, Hemanext, ISBT2020, News

Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with...

« Older Entries

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE

Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community

Science Innovation Forum

Hemanext Submits Hemanext ONE System to FDA For U.S. Marketing Authorization

Hemanext AABB 2021

Join Hemanext at AABB 2022 Virtual

Connect with Hemanext at ISBT 2020

Recent Posts